Drugmakers win $2.1bn US vaccine deal – Times of India
Business News
- Drugmakers win $2.1bn US vaccine deal Times of India
- U.S. agrees to pay Sanofi and GSK $2.1 billion for 100 million doses of coronavirus vaccine CNBC
- European drugmakers Sanofi and GSK strike $2.1 billion deal with U.S. for a coronavirus vaccine The Washington Post
- Trump’s Vaccine Chief Picks His Own Former Employer—Where He Still Holds Millions Worth of Stock—for $2.1 Billion Deal Common Dreams
- GSK on $2.1B vaccine supply deal with U.S. CNBC Television
- View Full Coverage on Google News
Source: Business News